The once-weekly injection, already approved in pediatric patients with GHD, offers convenience over daily injections.

First of many planned label expansions supporting Vision 2030 goal to become the leading endocrinology rare disease companyOn ...

Learn how better sleep leads to bigger gains and faster results in the gym by understanding how it drives muscle growth, ...

Lonapegsomatropin is a pegylated prodrug of the human growth hormone, somatropin, administered as a subcutaneous injection once-weekly.

The US Food and Drug Administration (FDA) has granted approval for Ascendis Pharma’s Skytrofa (lonapegsomatropin-tcgd, ...

Researchers at the University of Bath have developed a new technology that, for many patients could make injections a thing ...

Treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy are under review.

Researchers at UT Southwestern Medical Center have discovered how a hormone interacts with a receptor on the surface of ...

SaveHealth reports yeast infections, caused by Candida overgrowth, are common, treatable, and preventable with proper hygiene ...